Edge Therapeutics, Inc. Human Resources Contracts & Agreements
36 Contracts & Agreements
- Bonus & Incentive Agreements (9 contracts)
- Change of Control Agreements (1)
- Consulting Agreements (4)
- Employment Agreements (21)
- Separation Agreements (1)
- Executive Employment Agreement by and between Kirk V. Shephard, M.D. and PDS Biotechnology Corporation, effective as of January 22, 2024 (Filed With SEC on March 28, 2024)
- Executive Employment Agreement by and between Lars Boesgaard and PDS Biotechnology Corporation, effective as of November 28, 2023 (Filed With SEC on March 28, 2024)
- Third Amended and Restated PDS Biotechnology Corporation 2014 Equity Incentive Plan (Filed With SEC on July 17, 2023)
- Executive Employment Agreement by and between Spencer Brown and PDS Biotechnology Corporation, effective as of June 1, 2022 (Filed With SEC on August 8, 2022)
- Executive Employment Agreement by and between Lauren V. Wood, M.D. and PDS Biotechnology Corporation, effective as of March 14, 2022 (Filed With SEC on March 31, 2022)
- Executive Employment Agreement by and between Matthew Hill and PDS Biotechnology Corporation, effective as of March 14, 2022 (Filed With SEC on March 31, 2022)
- Executive Employment Agreement by and between Gregory Conn, Ph.D. and PDS Biotechnology Corporation, effective as of March 14, 2022 (Filed With SEC on March 31, 2022)
- Amended and Restated Executive Employment Agreement by and between Frank K. Bedu-Addo and PDS Biotechnology Corporation, effective as of March 14, 2022 (Filed With SEC on March 31, 2022)
- PDS Biotechnology Corporation Change of Control Severance Plan effective as of March 14, 2022 (Filed With SEC on March 31, 2022)
- Executive Employment Agreement by and between PDS Biotechnology Corporation and Matthew Hill, dated as of October 4, 2021 (Filed With SEC on October 6, 2021)
- Amendment to Employment Agreement by and between PDS Biotechnology Corporation and Gregory Conn, Ph.D., effective as of June 17, 2021 (Filed With SEC on June 21, 2021)
- Form of Employee Stock Option Agreement under the Second Amended and Restated PDS Biotechnology Corporation 2014 Equity Incentive Plan (Filed With SEC on December 9, 2020)
- Second Amended and Restated PDS Biotechnology Corporation 2014 Equity Incentive Plan (Filed With SEC on December 9, 2020)
- Executive Employment Agreement by and between the Company and Seth L. Van Voorhees, Ph.D (Filed With SEC on December 9, 2020)
- Consulting Agreement (Michael King) (Filed With SEC on June 24, 2020)
- Employment Agreement, effective June 1, 2019, by and between PDS Biotechnology Corporation and Gregory Conn (Filed With SEC on August 1, 2019)
- Consulting Services Agreement, dated March 26, 2015, by and between PDS Biotechnology Corporation and Gregory Conn (Filed With SEC on December 21, 2018)
- Consulting Services Agreement, dated December 15, 2014, by and between PDS Biotechnology Corporation and DeLyle Bloomquist (Filed With SEC on December 21, 2018)
- Consulting Services Agreement, dated December 15, 2014, by and between PDS Biotechnology Corporation and Gregory Freitag (Filed With SEC on December 21, 2018)
- Employment Agreement, dated October 11, 2018, by and between PDS Biotechnology Corporation and Frank K. Bedu-Addo (Filed With SEC on December 21, 2018)
- Executive Employment Agreement by and between Andrew Saik and Edge entered into as of October 31, 2017 (Filed With SEC on November 1, 2017)
- Separation and General Release Agreement, by and between Edge Therapeutics, Inc. and Andrew J. Einhorn, dated March 13, 2017 (Filed With SEC on March 15, 2017)
- Employment Agreement by and between Alyssa Wyant and the Company, dated as of February 21, 2017 (Filed With SEC on March 2, 2017)
- Executive Employment Agreement by and between Daniel Brennan and Edge Therapeutics, Inc. entered into as of October 17, 2016 (Filed With SEC on October 18, 2016)
- SECONDAMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on September 21, 2015)
- EDGE THERAPEUTICS, INC. 2014 EQUITY INCENTIVE PLAN Adopted by the Board of DirectorsAugust 27, 2014 Approved by the Shareholders November 3, 2014 (Filed With SEC on September 21, 2015)
- EDGE THERAPEUTICS, INC. 2012 EQUITY INCENTIVE PLAN (Filed With SEC on September 21, 2015)
- EDGE THERAPEUTICS, INC. 2010 EQUITY INCENTIVE PLAN (Filed With SEC on September 21, 2015)
- AMENDEDAND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 14, 2015)
- SECONDAMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 14, 2015)
- SECONDAMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 14, 2015)
- AMENDEDAND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 14, 2015)
- EDGE THERAPEUTICS,INC. SECOND AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 14, 2015)
- EDGE THERAPEUTICS, INC. 2014 EQUITY INCENTIVE PLAN Adopted by the Board of DirectorsAugust 27, 2014 Approved by the Shareholders November 3, 2014 (Filed With SEC on August 14, 2015)
- EDGE THERAPEUTICS, INC. 2012 EQUITY INCENTIVE PLAN (Filed With SEC on August 14, 2015)
- EDGE THERAPEUTICS, INC. 2010 EQUITY INCENTIVE PLAN (Filed With SEC on August 14, 2015)
